Bastion Asset Management Inc. Takes Position in The Cooper Companies, Inc. $COO

Bastion Asset Management Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 76,187 shares of the medical device company’s stock, valued at approximately $5,422,000. Cooper Companies makes up approximately 1.7% of Bastion Asset Management Inc.’s investment portfolio, making the stock its 26th largest position.

Several other institutional investors have also recently modified their holdings of the stock. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. SJS Investment Consulting Inc. increased its position in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the second quarter worth $36,000. True Wealth Design LLC raised its holdings in shares of Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its position in shares of Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on COO. Robert W. Baird decreased their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. BNP Paribas Exane decreased their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $81.85.

Cooper Companies Price Performance

COO stock opened at $73.10 on Friday. The stock has a market capitalization of $14.26 billion, a price-to-earnings ratio of 61.95, a price-to-earnings-growth ratio of 1.85 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The stock’s fifty day simple moving average is $66.01 and its 200-day simple moving average is $72.59.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the prior year, the firm posted $0.96 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.